These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37352455)

  • 41. COVID-19 vaccine-associated vitiligo: A cross-sectional study in a tertiary referral center and systematic review.
    Tsai TF; Ng CY
    J Dermatol; 2023 Aug; 50(8):982-989. PubMed ID: 37186102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do health insurers have an ethical responsibility to cover treatment of vitiligo?
    Bercovitch L
    Pediatr Dermatol; 2021 Nov; 38 Suppl 2():187. PubMed ID: 34850431
    [No Abstract]   [Full Text] [Related]  

  • 43. What is successful repigmentation in vitiligo from the point of view of patients?
    Narayan VS; Uitentuis SE; Bekkenk MW; Wolkerstorfer A
    Br J Dermatol; 2021 Jan; 184(1):165-166. PubMed ID: 32726875
    [No Abstract]   [Full Text] [Related]  

  • 44. Health-related quality of life in paediatric patients with vitiligo: a systematic review and meta-analysis.
    Nathalie J; Chang J; Ezzedine K; Rodrigues M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e755-e756. PubMed ID: 34013610
    [No Abstract]   [Full Text] [Related]  

  • 45. Vitiligo effectively treated with electrocautery needling technique.
    Yang L; Wong PM; Yang L; Katayama I; Wu H; Zhang H
    Dermatol Ther; 2020 Nov; 33(6):e14154. PubMed ID: 32767488
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States.
    Daniel SR; Gandhi K; Anastassopoulos KP; Pandya AG; Sikirica V; Patel R; Napatalung L; Yamaguchi Y; Baik R; Ezzedine K
    Br J Dermatol; 2022 Oct; 187(4):603-606. PubMed ID: 35596712
    [No Abstract]   [Full Text] [Related]  

  • 47. [A new method for correction of vitiliginous skin lesions].
    LINSER K
    Dtsch Gesundheitsw; 1961 Apr; 16():675-84. PubMed ID: 13762497
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment recommendations for patients with vitiligo during COVID-19.
    Rodrigues M; Pandya AG; Hamzavi I; Ezzedine K; Bekkenk MW; Harris JE
    Australas J Dermatol; 2021 Aug; 62(3):e481-e482. PubMed ID: 34028796
    [No Abstract]   [Full Text] [Related]  

  • 49. British Association of Dermatologists guidelines for the management of people with vitiligo 2021.
    Eleftheriadou V; Atkar R; Batchelor J; McDonald B; Novakovic L; Patel JV; Ravenscroft J; Rush E; Shah D; Shah R; Shaw L; Thompson AR; Hashme M; Exton LS; Mohd Mustapa MF; Manounah L;
    Br J Dermatol; 2022 Jan; 186(1):18-29. PubMed ID: 34160061
    [No Abstract]   [Full Text] [Related]  

  • 50. Micropigmentation-A revived therapeutic tool for recalcitrant, difficult-to-treat periungual vitiligo.
    Sharma A; Agrawal S; Dhurat R; Mhatre M; Surve R; Kerure A
    Dermatol Ther; 2020 Jul; 33(4):e13568. PubMed ID: 32401406
    [No Abstract]   [Full Text] [Related]  

  • 51. Vitiligo treatment with coloured illustration by Turkish physician Şerefeddin Sabuncuoğlu, in the 15th century.
    Serarslan G
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):472-473. PubMed ID: 36462153
    [No Abstract]   [Full Text] [Related]  

  • 52. Vitiligo: 30 years to put together the puzzle pieces and to give rise to a new era of therapeutic options.
    Passeron T
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2305-2307. PubMed ID: 34647661
    [No Abstract]   [Full Text] [Related]  

  • 53. Guideline for the diagnosis and management of vitiligo.
    Gawkrodger DJ; Ormerod AD; Shaw L; Mauri-Sole I; Whitton ME; Watts MJ; Anstey AV; Ingham J; Young K; ; ; ;
    Br J Dermatol; 2008 Nov; 159(5):1051-76. PubMed ID: 19036036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitiligo and quality of life: the dark face of whiteness.
    Ezzedine K; Eleftheriadou V
    Br J Dermatol; 2018 Jan; 178(1):28-29. PubMed ID: 29357599
    [No Abstract]   [Full Text] [Related]  

  • 56. Does low-intensity pulsed ultrasound enhance repigmentation in vitiligo?
    Sindhuja T; Chandra AD; Pathak M; Gupta V
    Dermatol Ther; 2022 Jul; 35(7):e15523. PubMed ID: 35439348
    [No Abstract]   [Full Text] [Related]  

  • 57. Vitiligo Impact Scale (VIS)-22: A measure of the psycho-social burden of vitiligo.
    Gupta V; Ramam M
    Indian J Dermatol Venereol Leprol; 2022; 88(5):691-695. PubMed ID: 35962518
    [No Abstract]   [Full Text] [Related]  

  • 58. How we treat vitiligo.
    Wilson JW; de Stefano RA
    Postgrad Med; 1970 May; 47(5):273-5. PubMed ID: 5422668
    [No Abstract]   [Full Text] [Related]  

  • 59. Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser.
    Murakami K; Saito Y; Takeuchi S; Sujino K; Tanikawa A; Tanese K; Fukuda K
    Eur J Dermatol; 2023 Aug; 33(4):428-430. PubMed ID: 37823495
    [No Abstract]   [Full Text] [Related]  

  • 60. Phototoxic reaction to Bakuchi seeds tried as home remedy in a patient of Vitiligo.
    Jha N
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.